{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:11:53Z","timestamp":1780445513488,"version":"3.54.1"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ZJU-Hangzhou Global Scientific and Technological Innovation Centre","award":["02120000-K020130001"],"award-info":[{"award-number":["02120000-K020130001"]}]},{"name":"Beijing Nova Program of Science and Technology","award":["20220484127"],"award-info":[{"award-number":["20220484127"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes &amp; Infections"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/22221751.2026.2623698","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:58:27Z","timestamp":1770739107000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Potent neutralization of Rift Valley fever virus mediated by monoclonal antibodies via concurrent inhibition of attachment and fusion"],"prefix":"10.1080","volume":"15","author":[{"given":"Meng","family":"Hao","sequence":"first","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]},{"name":"ZJU-Hangzhou Global Scientific and Technological Innovation Center","place":["Hangzhou, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bian","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]},{"name":"Institute of Veterinary Medicine","place":["Nanjing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshan","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcheng","family":"Fu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Chi","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Fan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Yu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Institute of Biotechnology","place":["Beijing, People\u2019s Republic of China"]},{"name":"ZJU-Hangzhou Global Scientific and Technological Innovation Center","place":["Hangzhou, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"2","key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","article-title":"Present and future arboviral threats","volume":"85","author":"Weaver SC","year":"2010","unstructured":"Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res. 2010;85(2):328\u2013345.","journal-title":"Antiviral Res"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa","volume":"34","author":"Daubney R","year":"1931","unstructured":"Daubney R, Hudson JR, Garnham PC. Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa. J Pathol Bacteriol. 1931;34:545\u2013579.","journal-title":"J Pathol Bacteriol"},{"issue":"1","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"e0005226","DOI":"10.1371\/journal.pntd.0005226","article-title":"Phylogeography of Rift Valley fever virus in Africa and the Arabian Peninsula","volume":"11","author":"Samy AM","year":"2017","unstructured":"Samy AM, Peterson AT, Hall M. Phylogeography of Rift Valley fever virus in Africa and the Arabian Peninsula. PLoS Negl Trop Dis. 2017;11(1):e0005226.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus","volume":"95","author":"Ikegami T.","year":"2012","unstructured":"Ikegami T. Molecular biology and genetic diversity of Rift Valley fever virus. Antiviral Res. 2012;95(3):293\u2013310.","journal-title":"Antiviral Res"},{"issue":"1","key":"e_1_3_4_6_1","first-page":"e4","article-title":"The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages","volume":"6","author":"Liu J","year":"2017","unstructured":"Liu J, Sun Y, Shi W, et al. The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages. Emerg Microbes Infect. 2017;6(1):e4.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4269\/ajtmh.16-0444","article-title":"Climate influence on emerging risk areas for Rift Valley fever epidemics in Tanzania","volume":"97","author":"Mweya CN","year":"2017","unstructured":"Mweya CN, Mboera LEG, Kimera SI. Climate influence on emerging risk areas for Rift Valley fever epidemics in Tanzania. Am J Trop Med Hyg. 2017;97(1):109\u2013114.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1073\/pnas.0806490106","article-title":"Prediction of a Rift Valley fever outbreak","volume":"106","author":"Anyamba A","year":"2009","unstructured":"Anyamba A, Chretien JP, Small J, et al. Prediction of a Rift Valley fever outbreak. Proc Natl Acad Sci U S A. 2009;106(3):955\u2013959.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/vaccines10111794","article-title":"An overview of Rift Valley fever vaccine development strategies","volume":"10","author":"Kitandwe PK","year":"2022","unstructured":"Kitandwe PK, McKay PF, Kaleebu P, et al. An overview of Rift Valley fever vaccine development strategies. Vaccines (Basel). 2022;10(11):1794.","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/vr.105.6.124","article-title":"An epizootic of Rift Valley fever in Egypt in 1977","volume":"105","author":"Meegan JM","year":"1979","unstructured":"Meegan JM, Hoogstraal H, Moussa MI. An epizootic of Rift Valley fever in Egypt in 1977. Vet Rec. 1979;105(6):124\u2013125.","journal-title":"Vet Rec"},{"issue":"2","key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4269\/ajtmh.2010.09-0292","article-title":"Rift Valley fever outbreak in livestock in Kenya, 2006-2007","volume":"83","author":"Munyua P","year":"2010","unstructured":"Munyua P, Murithi RM, Wainwright S, et al. Rift Valley fever outbreak in livestock in Kenya, 2006-2007. Am J Trop Med Hyg. 2010;83(2 Suppl):58\u201364.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4269\/ajtmh.2010.09-0291","article-title":"An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya","volume":"83","author":"Rich KM","year":"2010","unstructured":"Rich KM, Wanyoike F. An assessment of the regional and national socio-economic impacts of the 2007 Rift Valley fever outbreak in Kenya. Am J Trop Med Hyg. 2010;83(2 Suppl):52\u201357.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever","volume":"3","author":"Ikegami T","year":"2011","unstructured":"Ikegami T, Makino S. The pathogenesis of Rift Valley fever. Viruses. 2011;3(5):493\u2013519.","journal-title":"Viruses"},{"issue":"8","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s00705-017-3358-5","article-title":"Changes to taxonomy and the international code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2017)","volume":"162","author":"Adams MJ","year":"2017","unstructured":"Adams MJ, Lefkowitz EJ, King AMQ, et al. Changes to taxonomy and the international code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch Virol. 2017;162(8):2505\u20132538.","journal-title":"Arch Virol"},{"issue":"5","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1073\/pnas.1217780110","article-title":"Crystal structure of glycoprotein C from Rift Valley fever virus","volume":"110","author":"Dessau M","year":"2013","unstructured":"Dessau M, Modis Y. Crystal structure of glycoprotein C from Rift Valley fever virus. Proc Natl Acad Sci U S A. 2013;110(5):1696\u20131701.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/v8070202","article-title":"The role of phlebovirus glycoproteins in viral entry, assembly and release","volume":"8","author":"Spiegel M","year":"2016","unstructured":"Spiegel M, Plegge T, Pohlmann S. The role of phlebovirus glycoproteins in viral entry, assembly and release. Viruses. 2016;8(7):202.","journal-title":"Viruses"},{"issue":"36","key":"e_1_3_4_17_1","first-page":"E7564","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu Y","year":"2017","unstructured":"Wu Y, Zhu Y, Gao F, et al. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci U S A. 2017;114(36):E7564\u2013E7573.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41467-017-02789-2","article-title":"Shielding and activation of a viral membrane fusion protein","volume":"9","author":"Halldorsson S","year":"2018","unstructured":"Halldorsson S, Li S, Li M, et al. Shielding and activation of a viral membrane fusion protein. Nat Commun. 2018;9(1):349.","journal-title":"Nat Commun"},{"issue":"21","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1128\/JVI.01191-08","article-title":"Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography","volume":"82","author":"Freiberg AN","year":"2008","unstructured":"Freiberg AN, Sherman MB, Morais MC, et al. Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography. J Virol. 2008;82(21):10341\u20138.","journal-title":"J Virol"},{"issue":"8","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1128\/JVI.02483-08","article-title":"Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers","volume":"83","author":"Huiskonen JT","year":"2009","unstructured":"Huiskonen JT, Overby AK, Weber F, et al. Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers. J Virol. 2009;83(8):3762\u20133769.","journal-title":"J Virol"},{"issue":"23","key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"12954","DOI":"10.1128\/JVI.02242-12","article-title":"Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis","volume":"86","author":"Harmon B","year":"2012","unstructured":"Harmon B, Schudel BR, Maar D, et al. Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis. J Virol. 2012;86(23):12954\u201312970.","journal-title":"J Virol"},{"issue":"6","key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.chom.2010.05.007","article-title":"Entry of bunyaviruses into mammalian cells","volume":"7","author":"Lozach PY","year":"2010","unstructured":"Lozach PY, Mancini R, Bitto D, et al. Entry of bunyaviruses into mammalian cells. Cell Host Microbe. 2010;7(6):488\u2013499.","journal-title":"Cell Host Microbe"},{"issue":"24","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"13642","DOI":"10.1128\/JVI.01973-12","article-title":"Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein","volume":"86","author":"de Boer SM","year":"2012","unstructured":"de Boer SM, Kortekaas J, Spel L, et al. Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol. 2012;86(24):13642\u201313652.","journal-title":"J Virol"},{"issue":"6363","key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aal2712","article-title":"A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion","volume":"358","author":"Guardado-Calvo P","year":"2017","unstructured":"Guardado-Calvo P, Atkovska K, Jeffers SA, et al. A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion. Science. 2017;358(6363):663\u2013667.","journal-title":"Science"},{"issue":"36","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"14926","DOI":"10.1073\/pnas.1112149108","article-title":"Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice","volume":"108","author":"Papin JF","year":"2011","unstructured":"Papin JF, Verardi PH, Jones LA, et al. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice. Proc Natl Acad Sci U S A. 2011;108(36):14926\u201314931.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41541-023-00763-2","article-title":"A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques","volume":"8","author":"Bian T","year":"2023","unstructured":"Bian T, Hao M, Zhao X, et al. A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques. NPJ Vaccines. 2023;8(1):164.","journal-title":"NPJ Vaccines"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"907675","DOI":"10.3389\/fimmu.2022.907675","article-title":"Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge","volume":"13","author":"Bian T","year":"2022","unstructured":"Bian T, Wang B, Fu G, et al. Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge. Front Immunol. 2022;13:907675.","journal-title":"Front Immunol"},{"issue":"1","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41541-020-00218-y","article-title":"A protective bivalent vaccine against Rift Valley fever and bluetongue","volume":"5","author":"Calvo-Pinilla E","year":"2020","unstructured":"Calvo-Pinilla E, Marin-Lopez A, Moreno S, et al. A protective bivalent vaccine against Rift Valley fever and bluetongue. NPJ Vaccines. 2020;5(1):70.","journal-title":"NPJ Vaccines"},{"issue":"3","key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/v12030259","article-title":"Characterization of two neutralizing antibodies against Rift Valley fever virus Gn protein","volume":"12","author":"Hao M","year":"2020","unstructured":"Hao M, Zhang G, Zhang S, et al. Characterization of two neutralizing antibodies against Rift Valley fever virus Gn protein. Viruses. 2020;12(3):259.","journal-title":"Viruses"},{"issue":"7","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41564-019-0411-z","article-title":"Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus","volume":"4","author":"Wang Q","year":"2019","unstructured":"Wang Q, Ma T, Wu Y, et al. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat Microbiol. 2019;4(7):1231\u20131241.","journal-title":"Nat Microbiol"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"1114226","DOI":"10.3389\/fmicb.2023.1114226","article-title":"An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice","volume":"14","author":"Hao M","year":"2023","unstructured":"Hao M, Bian T, Fu G, et al. An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice. Front Microbiol. 2023;14:1114226.","journal-title":"Front Microbiol"},{"issue":"1","key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.immuni.2022.12.005","article-title":"Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies","volume":"56","author":"Pushparaj P","year":"2023","unstructured":"Pushparaj P, Nicoletto A, Sheward DJ, et al. Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies. Immunity. 2023;56(1):193\u2013206.e7.","journal-title":"Immunity"},{"issue":"10","key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"113194","DOI":"10.1016\/j.celrep.2023.113194","article-title":"Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity","volume":"42","author":"Yuan M","year":"2023","unstructured":"Yuan M, Feng Z, Lv H, et al. Widespread impact of immunoglobulin V-gene allelic polymorphisms on antibody reactivity. Cell Rep. 2023;42(10):113194.","journal-title":"Cell Rep"},{"issue":"17","key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-\/-) mice induced by different DNA vaccination regimens","volume":"28","author":"Lorenzo G","year":"2010","unstructured":"Lorenzo G, Martin-Folgar R, Hevia E, et al. Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-\/-) mice induced by different DNA vaccination regimens. Vaccine. 2010;28(17):2937\u20132944.","journal-title":"Vaccine"},{"issue":"14","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"e2025642118","DOI":"10.1073\/pnas.2025642118","article-title":"Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition","volume":"118","author":"Chapman NS","year":"2021","unstructured":"Chapman NS, Zhao H, Kose N, et al. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proc Natl Acad Sci U S A. 2021;118(14):e2025642118.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.virol.2006.07.035","article-title":"Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors","volume":"356","author":"Filone CM","year":"2006","unstructured":"Filone CM, Heise M, Doms RW, et al. Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors. Virology. 2006;356(1-2):155\u2013164.","journal-title":"Virology"},{"issue":"1","key":"e_1_3_4_37_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42003-023-04927-7","article-title":"ImmuneBuilder: deep-learning models for predicting the structures of immune proteins","volume":"6","author":"Abanades B","year":"2023","unstructured":"Abanades B, Wong WK, Boyles F, et al. ImmuneBuilder: deep-learning models for predicting the structures of immune proteins. Commun Biol. 2023;6(1):575.","journal-title":"Commun Biol"},{"issue":"2","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.169","article-title":"The ClusPro web server for protein-protein docking","volume":"12","author":"Kozakov D","year":"2017","unstructured":"Kozakov D, Hall DR, Xia B, et al. The ClusPro web server for protein-protein docking. Nat Protoc. 2017;12(2):255\u2013278.","journal-title":"Nat Protoc"},{"issue":"3","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/vaccines5030029","article-title":"Current status of Rift Valley fever vaccine development","volume":"5","author":"Faburay B","year":"2017","unstructured":"Faburay B, LaBeaud AD, McVey DS, et al. Current status of Rift Valley fever vaccine development. Vaccines (Basel). 2017;5(3):29.","journal-title":"Vaccines (Basel)"},{"issue":"13","key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1016\/j.celrep.2018.12.001","article-title":"A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus","volume":"25","author":"Allen ER","year":"2018","unstructured":"Allen ER, Krumm SA, Raghwani J, et al. A protective monoclonal antibody targets a site of vulnerability on the surface of Rift Valley fever virus. Cell Rep. 2018;25(13):3750\u20133758.e4.","journal-title":"Cell Rep"},{"issue":"1","key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/vim.1989.2.31","article-title":"Human monoclonal antibodies to influenza virus: IgG subclass and light chain distribution","volume":"2","author":"Frank AL","year":"1989","unstructured":"Frank AL, Six HR, Marchini A. Human monoclonal antibodies to influenza virus: IgG subclass and light chain distribution. Viral Immunol. 1989;2(1):31\u201336.","journal-title":"Viral Immunol"},{"issue":"11","key":"e_1_3_4_42_1","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.1701174","article-title":"Infection of ferrets with influenza virus elicits a light chain-biased antibody response against hemagglutinin","volume":"199","author":"Kirchenbaum GA","year":"2017","unstructured":"Kirchenbaum GA, Allen JD, Layman TS, et al. Infection of ferrets with influenza virus elicits a light chain-biased antibody response against hemagglutinin. J Immunol. 2017;199(11):3798\u20133807.","journal-title":"J Immunol"},{"issue":"1","key":"e_1_3_4_43_1","doi-asserted-by":"crossref","first-page":"7854","DOI":"10.1038\/s41467-022-35575-w","article-title":"Molecular mechanism of antibody neutralization of coxsackievirus A16","volume":"13","author":"Zhang C","year":"2022","unstructured":"Zhang C, Liu C, Shi J, et al. Molecular mechanism of antibody neutralization of coxsackievirus A16. Nat Commun. 2022;13(1):7854.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_4_44_1","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1038\/s41467-020-18828-4","article-title":"Structural characterization of the ICOS\/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies","volume":"11","author":"Rujas E","year":"2020","unstructured":"Rujas E, Cui H, Sicard T, et al. Structural characterization of the ICOS\/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies. Nat Commun. 2020;11(1):5066.","journal-title":"Nat Commun"},{"issue":"11","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.celrep.2015.11.043","article-title":"Neutralizing monoclonal antibodies block chikungunya virus entry and release by targeting an epitope critical to viral pathogenesis","volume":"13","author":"Jin J","year":"2015","unstructured":"Jin J, Liss NM, Chen DH, et al. Neutralizing monoclonal antibodies block chikungunya virus entry and release by targeting an epitope critical to viral pathogenesis. Cell Rep. 2015;13(11):2553\u20132564.","journal-title":"Cell Rep"},{"issue":"19","key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"e00252-20","DOI":"10.1128\/JVI.00252-20","article-title":"Anti-Chikungunya virus monoclonal antibody that inhibits viral fusion and release","volume":"94","author":"Tumkosit U","year":"2020","unstructured":"Tumkosit U, Siripanyaphinyo U, Takeda N, et al. Anti-Chikungunya virus monoclonal antibody that inhibits viral fusion and release. J Virol. 2020;94(19):e00252-20.","journal-title":"J Virol"},{"issue":"1","key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/s41467-024-51108-z","article-title":"A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection","volume":"15","author":"Ren X","year":"2024","unstructured":"Ren X, Sun J, Kuang W, et al. A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection. Nat Commun. 2024;15(1):7009.","journal-title":"Nat Commun"},{"issue":"1","key":"e_1_3_4_48_1","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1038\/s41467-023-41171-3","article-title":"Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses","volume":"14","author":"Chapman NS","year":"2023","unstructured":"Chapman NS, Hulswit RJG, Westover JLB, et al. Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses. Nat Commun. 2023;14(1):5650.","journal-title":"Nat Commun"},{"issue":"6","key":"e_1_3_4_49_1","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"Ikegami T","year":"2006","unstructured":"Ikegami T, Won S, Peters CJ, et al. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol. 2006;80(6):2933\u20132940.","journal-title":"J Virol"},{"key":"e_1_3_4_50_1","doi-asserted-by":"crossref","first-page":"W34","DOI":"10.1093\/nar\/gkt382","article-title":"IgBLAST: an immunoglobulin variable domain sequence analysis tool","volume":"41","author":"Ye J","year":"2013","unstructured":"Ye J, Ma N, Madden TL, et al. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 2013;41(Web Server issue):W34\u2013W40.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_4_51_1","doi-asserted-by":"crossref","unstructured":"Lefranc MP. IMGT the international ImMunoGeneTics information system http:\/\/imgt.cines.fr. Novartis Found Symp. 2003;254:126-36; discussion 136-42 216-22 250-2.","DOI":"10.1002\/0470090766.ch9"},{"issue":"11","key":"e_1_3_4_52_1","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1128\/JCM.00936-07","article-title":"Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus","volume":"45","author":"Bird BH","year":"2007","unstructured":"Bird BH, Bawiec DA, Ksiazek TG, et al. Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus. J Clin Microbiol. 2007;45(11):3506\u20133513.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"e_1_3_4_53_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/antib13040099","article-title":"50 years of antibody numbering schemes: a statistical and structural evaluation reveals key differences and limitations","volume":"13","author":"Zhu Z","year":"2024","unstructured":"Zhu Z, Olson KS, Magliery TJ. 50 years of antibody numbering schemes: a statistical and structural evaluation reveals key differences and limitations. Antibodies (Basel). 2024;13(4):99.","journal-title":"Antibodies (Basel)"},{"issue":"11","key":"e_1_3_4_54_1","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng EC","year":"2023","unstructured":"Meng EC, Goddard TD, Pettersen EF, et al. UCSF ChimeraX: tools for structure building and analysis. Protein Sci. 2023;32(11):e4792.","journal-title":"Protein Sci"},{"issue":"10","key":"e_1_3_4_55_1","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski RA","year":"2011","unstructured":"Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778\u20132786.","journal-title":"J Chem Inf Model"}],"container-title":["Emerging Microbes &amp; Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/22221751.2026.2623698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:58:33Z","timestamp":1770739113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/22221751.2026.2623698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/22221751.2026.2623698"],"URL":"https:\/\/doi.org\/10.1080\/22221751.2026.2623698","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2623698"}}